S
SeaStar Medical Holding Corp
NASDAQ:ICU
SeaStar Medical Holding Corp
NASDAQ:ICU
Price:
3.71
USD
-8.62%
Market Closed
Market Cap:
$14.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SeaStar Medical Holding Corp
NASDAQ:ICU
|
US |
|
Osteopore Ltd
ASX:OSX
|
AU |
Income Statement
Earnings Waterfall
SeaStar Medical Holding Corp
SeaStar Medical Holding Corp
Income Statement
SeaStar Medical Holding Corp
SeaStar Medical Holding Corp
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+99%
|
0
+217%
|
1
+79%
|
1
+15%
|
1
+40%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+99%
|
0
+217%
|
1
+73%
|
1
+14%
|
1
+41%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(4)
|
(4)
|
(4)
|
(5)
|
(12)
|
(15)
|
(18)
|
(19)
|
(14)
|
(19)
|
(19)
|
(16)
|
(18)
|
(18)
|
(16)
|
(15)
|
(13)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(3)
|
(7)
|
(10)
|
(11)
|
(11)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(8)
|
(7)
|
(7)
|
(6)
|
|
| Research & Development |
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(10)
|
(9)
|
(8)
|
(8)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(4)
+6%
|
(4)
-3%
|
(5)
-14%
|
(12)
-135%
|
(15)
-32%
|
(18)
-16%
|
(19)
-7%
|
(14)
+25%
|
(19)
-30%
|
(19)
-5%
|
(16)
+18%
|
(18)
-11%
|
(18)
+1%
|
(15)
+16%
|
(14)
+6%
|
(12)
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(3)
|
(2)
|
(2)
|
(1)
|
2
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(11)
|
(11)
|
(7)
|
(12)
|
(12)
|
(12)
|
(6)
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(5)
N/A
|
(5)
+1%
|
(4)
+5%
|
(5)
-16%
|
(23)
-359%
|
(27)
-19%
|
(30)
-10%
|
(36)
-18%
|
(26)
+26%
|
(34)
-28%
|
(33)
+1%
|
(30)
+9%
|
(25)
+18%
|
(16)
+36%
|
(15)
+8%
|
(14)
+7%
|
(12)
+11%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(5)
|
(5)
|
(4)
|
(5)
|
(23)
|
(27)
|
(30)
|
(36)
|
(26)
|
(34)
|
(33)
|
(30)
|
(25)
|
(16)
|
(15)
|
(14)
|
(12)
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
+1%
|
(4)
+5%
|
(5)
-16%
|
(23)
-359%
|
(27)
-19%
|
(30)
-10%
|
(36)
-18%
|
(26)
+26%
|
(34)
-28%
|
(33)
+1%
|
(30)
+9%
|
(25)
+18%
|
(16)
+36%
|
(15)
+8%
|
(14)
+7%
|
(12)
+11%
|
|
| EPS (Diluted) |
-90.55
N/A
|
-89.37
+1%
|
-85.23
+5%
|
-98.62
-16%
|
-452.95
-359%
|
-523.41
-16%
|
-502.92
+4%
|
-443.64
+12%
|
-302.63
+32%
|
-125.43
+59%
|
-105.34
+16%
|
-74.1
+30%
|
-66.33
+10%
|
-18.45
+72%
|
-12.94
+30%
|
-5.17
+60%
|
-5.86
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
